THERMO FISHER SCIENTIFIC INC. 8-K

What Happened
Thermo Fisher Scientific (TMO) filed an 8-K (Item 5.02) on January 12, 2026, announcing that two senior executives are leaving and the company will reorganize its leadership effective March 1, 2026. Michel Lagarde, Executive Vice President and Chief Operating Officer since 2021, will depart on March 31, 2026. Frederick M. Lowery, an Executive Vice President since 2024, will depart on February 28, 2026. The company said Marc N. Casper will become Chairman and Chief Executive Officer; Gianluca Pettiti will be promoted to President and Chief Operating Officer; and Michael Shafer will be promoted to an expanded role reporting directly to the CEO.

Key Details

• Filing: Form 8-K (Item 5.02) filed January 12, 2026.
• Departures: Michel Lagarde leaving effective March 31, 2026; Frederick M. Lowery leaving effective February 28, 2026.
• Effective reorganize date: March 1, 2026 — Marc N. Casper named Chairman & CEO; Gianluca Pettiti promoted to President & COO; Michael Shafer promoted and will report directly to the CEO.
• Roles/history: Lagarde served as EVP & COO since 2021; Lowery served as an Executive VP since 2024.

Why It Matters
These are material senior leadership changes that reassign top operational responsibilities and clarify reporting lines at Thermo Fisher. For investors, the filing signals a planned leadership transition and organizational update (effective March 1, 2026) that may affect execution and management continuity. Monitor future company disclosures for any additional details on succession, strategic direction, or compensation tied to these changes.